D. Bouchard et al., VASCULAR EFFECTS OF CYCLOSPORINE-A AND ACUTE REJECTION IN CANINE HEART-TRANSPLANTATION, The Annals of thoracic surgery, 64(5), 1997, pp. 1325-1330
Background. Alteration of coronary vascular regulation during acute re
jection may induce graft dysfunction and promote the occurrence of cor
onary atherosclerosis in transplant recipients. We studied the effects
of treated and untreated acute rejection on coronary vascular regulat
ion. Methods. Two groups of mongrel dogs (n = 7) underwent heterotopic
heart transplantation (cervical position) and received either no trea
tment (group 1) or cyclosporin A (CyA), 10 mg.kg(-1).day(-1) (group 2)
. On day 7, recipient native and transplanted hearts were harvested an
d studied in organ chambers for coronary vascular reactivity. Results.
Transplanted hearts from group 1 displayed grade IV histologic reject
ion, whereas those from group 2 displayed grade IIIA to IV rejection.
Intimal hyperplasia was found in the coronary arteries of both groups.
Immunoperoxidase staining revealed the presence of factor VIII and of
immunoglobulin M and G antibodies on the endothelium of both groups.
Coronary relaxation to thrombin was impaired in transplanted hearts co
mpared with native hearts (p < 0.05), and this was not influenced by C
yA treatment. Conversely, endothelium-dependent relaxation to 5-hydrox
ytryptamine was enhanced in both CyA-treated (p < 0.01) and untreated
groups (p < 0.05). A facilitating effect of CyA on 5-hydroxytryptamine
also was seen in transplanted hearts in group 1 versus group 2 (p < 0
.05), suggesting an intrinsic effect of CyA. Endothelium-independent r
elaxation to sodium nitroprusside and the contractile response to pros
taglandin F-2 alpha were not affected. Conclusions. In our model, acut
e rejection did not specifically impair cyclic guanosine monophosphate
-mediated relaxation, but it did affect, in a receptor-specific manner
, endothelium-dependent relaxation. Cyclosporin A appeared to enhance
coronary endothelial sensitivity to 5-hydroxytryptamine. (C) 1997 by T
he Society of Thoracic Surgeons.